June 2026 in “Mendeley Data” This source presents the Drug Database for Hair Loss Disorders, offering comprehensive details about pharmacological agents for treating hair loss conditions, including information on chemical properties, efficacy, and safety, aimed at supporting research and drug development.
June 2026 in “Mendeley Data” This study introduced the Drug Database for Hair Loss Disorders, which provides comprehensive details on pharmacological agents used to treat hair loss conditions, aiding research and development efforts in drug companies through accessible chemical properties, mechanisms, and efficacy data.
This study developed a convolutional neural network model for non-invasive diagnosis of androgenetic alopecia using dermoscopic images, demonstrating potential accuracy and scalability while highlighting the importance of model interpretability for clinical use.
August 1988 in “Journal of the Royal Society of Medicine” Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.
July 2026 in “International Journal of Advanced Research in Science Communication and Technology” In this study, the BaldGraphFormer framework, integrating visual and clinical data, outperformed unimodal baselines in early-stage androgenetic alopecia detection, achieving an F1-score of 97.62% and macro-average AUC of 0.992, suggesting its potential to support dermatological decision-making and early intervention.
